Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.446303.192678Peak area normalizedmale diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.446610.30652Peak area normalizedmale diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.447338.053764Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.447646.010588Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.448552.627229Peak area normalizedmale pre-diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.449118.055895Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.449131.44241Peak area normalizedmale pre-diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4411242.53819Peak area normalizedfemale normoglycemic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4412731.15181Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4414975.70957Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4425233.15775Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4425237.9998Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4431155.50925Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4442607.47894Peak area normalizedfemale normoglycemic Neuropathy

Return to search page
  logo